Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.24%
#2 aelf aelf +23.74%
#3 Decred Decred +12.08%
#4 Bitway Bitway +10.57%
#5 AtomOne AtomOne +10.54%
#6 TRIA TRIA +9.39%
#7 Pons Pons +8.39%
#8 Wibx Wibx +8.12%
#9 Status Status +7.87%
#10 Starpower Starpower +7.61%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Aprogen Biologics Inc. Aprogen Biologics Inc.

Aprogen Biologics Inc.

003060
Rank in Stocks #30308
Aprogen Biologics, Inc. specializes in the production and distribution of... Aprogen Biologics, Inc. specializes in the production and distribution of pharmaceutical goods. The company's activities are structured across two main segments: Pharmaceutical and Bio. Its Pharmaceutical division supplies synthetic medicines, encompassing treatments for the circulatory, central nervous, and digestive systems, alongside antibiotics. Concurrently, the Bio division is dedicated to developing and manufacturing biopharmaceuticals. Aprogen Biologics was established on December 3, 1960, and its corporate headquarters are situated in Seoul, South Korea.
Share Price
$1.31
Market Cap
$17.30M
Change (1 day)
-2.57%
Change (1 year)
-80.96%
Country
KR
Trade Aprogen Biologics Inc. (003060)

Category

Healthcare
P/E ratio for Aprogen Biologics Inc. (003060)
P/E ratio as of 2026 TTM: 0
According to Aprogen Biologics Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Aprogen Biologics Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.